{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:44:30Z","timestamp":1791067470208,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.bone.2008.09.012","type":"journal-article","created":{"date-parts":[[2008,10,8]],"date-time":"2008-10-08T18:54:40Z","timestamp":1223492080000},"page":"4-10","source":"Crossref","is-referenced-by-count":215,"title":["Osteonecrosis of the jaw \u2014 Who gets it, and why?"],"prefix":"10.1016","volume":"44","author":[{"given":"Ian R.","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2008.09.012_bib1","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J. Bone Mineral Res."},{"key":"10.1016\/j.bone.2008.09.012_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.joms.2006.11.003","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws","volume":"65","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib3","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J. Bone Mineral Res."},{"key":"10.1016\/j.bone.2008.09.012_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jcms.2007.06.008","article-title":"Bis-phossy jaws\u201d \u2014 high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw","volume":"36","author":"Abu-Id","year":"2008","journal-title":"J. Cranio-Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib5","first-page":"3078","article-title":"Kiefernekrosen nach hoch dosierter Bisphosphonattherapie","volume":"103","author":"Felsenberg","year":"2006","journal-title":"Dtsch. \u00c4rztebl."},{"key":"10.1016\/j.bone.2008.09.012_bib6","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1902\/jop.2007.060514","article-title":"Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices","volume":"78","author":"Fugazzotto","year":"2007","journal-title":"J. Periodontol."},{"key":"10.1016\/j.bone.2008.09.012_bib7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.joms.2007.12.040","article-title":"Oral bisphosphonates and dental implants: a retrospective study","volume":"66","author":"Bell","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.joms.2007.09.019","article-title":"Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases","volume":"66","author":"Grant","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib9","first-page":"349","article-title":"Safety of oral bisphosphonates: controlled studies on alveolar bone","volume":"21","author":"Jeffcoat","year":"2006","journal-title":"Int. J. Oral Maxillofac. Implants"},{"key":"10.1016\/j.bone.2008.09.012_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","article-title":"Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case\u2013control study","volume":"66","author":"Wessel","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib11","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1210\/jc.2006-2036","article-title":"Possible association between diabetes and bisphosphonate-related jaw osteonecrosis","volume":"92","author":"Khamaisi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"suppl","key":"10.1016\/j.bone.2008.09.012_bib12","doi-asserted-by":"crossref","first-page":"8528","DOI":"10.1200\/jco.2006.24.18_suppl.8528","article-title":"Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy","volume":"24","author":"Hoff","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2008.09.012_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.012_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3816\/CLM.2008.n.013","article-title":"Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid","volume":"8","author":"Cafro","year":"2008","journal-title":"Clin. Lyphoma. Myeloma."},{"key":"10.1016\/j.bone.2008.09.012_bib15","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jnci\/djm025","article-title":"Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: a population-based analysis","volume":"99","author":"Wilkinson","year":"2007","journal-title":"J. Natl. Canc. Inst."},{"key":"10.1016\/j.bone.2008.09.012_bib16","first-page":"23","article-title":"Bisphosphonate use and the risk of adverse jaw outcomes","volume":"139","author":"Cartsos","year":"2008","journal-title":"JADA"},{"key":"10.1016\/j.bone.2008.09.012_bib17","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-007-0384-2","article-title":"Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome","volume":"18","author":"Yarom","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2008.09.012_bib18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.012_bib19","first-page":"32","article-title":"Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial","volume":"139","author":"Grbic","year":"2008","journal-title":"JADA"},{"key":"10.1016\/j.bone.2008.09.012_bib20","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.012_bib21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00198-007-0502-1","article-title":"Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker","volume":"19","author":"Pazianas","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2008.09.012_bib22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","article-title":"Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease","volume":"353","author":"Reid","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.012_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0714.2007.00607.x","article-title":"No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates","volume":"37","author":"Malmgren","year":"2008","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.bone.2008.09.012_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","article-title":"Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia","volume":"65","author":"Mavrokokki","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates \u2014 histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.bone.2008.09.012_bib26","first-page":"6538","article-title":"Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats","volume":"62","author":"Fournier","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2008.09.012_bib27","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.joms.2007.11.035","article-title":"Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy","volume":"66","author":"Sedghizadeh","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMcpc0800341","article-title":"A woman with a nonhealing ulcer of the jaw \u2014 Gingival ulceration, inflammation, and acute osteomyelitis with actinomyces, all associated with necrosis of bone (bisphosphonate-related osteonecrosis of bone)","volume":"358","author":"Dodson","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.012_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00428-006-0261-y","article-title":"Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis \u2014 a paradoxical observation?","volume":"449","author":"Hansen","year":"2006","journal-title":"Virchows. Archiv."},{"key":"10.1016\/j.bone.2008.09.012_bib30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1259\/dmfr\/27458726","article-title":"Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws","volume":"35","author":"Chiandussi","year":"2006","journal-title":"Dentomaxillofac. Radiol."},{"key":"10.1016\/j.bone.2008.09.012_bib31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.crad.2007.04.023","article-title":"Biphosphonate-induced osteonecrosis of the jaws: CT and MRI spectrum of findings in 32 patients","volume":"63","author":"Bisdas","year":"2008","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.bone.2008.09.012_bib32","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/00016350600844360","article-title":"Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws","volume":"64","author":"Biasotto","year":"2006","journal-title":"Acta Odontol. Scand."},{"key":"10.1016\/j.bone.2008.09.012_bib33","article-title":"Osteonecrosis of the jaw","author":"Reid","year":"2008","journal-title":"Skelet. Radiol."},{"key":"10.1016\/j.bone.2008.09.012_bib34","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","article-title":"Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment","volume":"65","author":"Marx","year":"2007","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density","volume":"346","author":"Reid","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.012_bib36","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","article-title":"Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis","volume":"12","author":"Khan","year":"1997","journal-title":"J. Bone Mineral Res."},{"key":"10.1016\/j.bone.2008.09.012_bib37","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/0091270002239824","article-title":"The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function","volume":"43","author":"Skerjanec","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bone.2008.09.012_bib38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0090-9556(25)08706-9","article-title":"Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats","volume":"20","author":"Lin","year":"1992","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bone.2008.09.012_bib39","first-page":"336","article-title":"Bone turnover in elderly canine mandible and tibia","volume":"76","author":"Dixon","year":"1997","journal-title":"J. Dental Res."},{"issue":"Suppl","key":"10.1016\/j.bone.2008.09.012_bib40","first-page":"502","article-title":"Alveolar bone remodelling in the rat: normal status and effects of PTX and PTH on the remodelling sequence and the osteoclastic pool","volume":"22","author":"Baron","year":"1977","journal-title":"Calcif. Tissue Res."},{"key":"10.1016\/j.bone.2008.09.012_bib41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bone.2007.04.196","article-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","volume":"41","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.09.012_bib42","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.bone.2007.12.225","article-title":"Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells","volume":"42","author":"Coxon","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.09.012_bib43","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/mol.105.020776","article-title":"Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis","volume":"69","author":"Thompson","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bone.2008.09.012_bib44","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","article-title":"Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment","volume":"66","author":"Allen","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00508-006-0644-8","article-title":"Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients","volume":"118","author":"Wutzl","year":"2006","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.bone.2008.09.012_bib46","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"key":"10.1016\/j.bone.2008.09.012_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anaerobe.2007.12.001","article-title":"Actinomyces\u2014gathering evidence of human colonization and infection","volume":"14","author":"Hall","year":"2008","journal-title":"Anaerobe"},{"key":"10.1016\/j.bone.2008.09.012_bib48","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","volume":"284","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bone.2008.09.012_bib49","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1128\/IAI.64.7.2371-2380.1996","article-title":"Bacterially induced bone destruction: mechanisms and misconceptions","volume":"64","author":"Nair","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bone.2008.09.012_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.micpath.2007.03.001","article-title":"Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains","volume":"43","author":"Belibasakis","year":"2007","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bone.2008.09.012_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2005.02665.x","article-title":"The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gamma delta T cells in response to aminobisphosphonates is inhibited by statins","volume":"139","author":"Hewitt","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.bone.2008.09.012_bib52","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2141.2006.06445.x","article-title":"Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway","volume":"136","author":"Ishikawa","year":"2007","journal-title":"Brit. J. Haematol."},{"key":"10.1016\/j.bone.2008.09.012_bib53","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-9657.2005.00434.x","article-title":"Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts","volume":"22","author":"Correia","year":"2006","journal-title":"Dental Traumatol."},{"key":"10.1016\/j.bone.2008.09.012_bib54","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bbrc.2007.01.014","article-title":"Alendronate suppresses tumor angiogenesis by inhibiting Rho activation of endothelial cells","volume":"354","author":"Hashimoto","year":"2007","journal-title":"Biochem. Biophys. Res. Comm."},{"key":"10.1016\/j.bone.2008.09.012_bib55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-9657.2005.00370.x","article-title":"Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. A pilot study","volume":"21","author":"Moreira","year":"2005","journal-title":"Dent. Traumatol."},{"key":"10.1016\/j.bone.2008.09.012_bib56","first-page":"1109","article-title":"Clodronate inhibits angiogenesis in vitro and in vivo","volume":"19","author":"Ribatti","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bone.2008.09.012_bib57","doi-asserted-by":"crossref","first-page":"6222S","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2008.09.012_bib58","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/mol.59.2.193","article-title":"Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation","volume":"59","author":"Reszka","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bone.2008.09.012_bib59","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphosphonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2008.09.012_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdn526","article-title":"Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan","author":"Ripamonti","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bone.2008.09.012_bib61","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/sj.leu.2404682","article-title":"A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma","volume":"21","author":"Corso","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bone.2008.09.012_bib62","first-page":"971","article-title":"The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors","volume":"138","author":"Adornato","year":"2007","journal-title":"JADA"},{"key":"10.1016\/j.bone.2008.09.012_bib63","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4065\/81.8.1100","article-title":"Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy","volume":"81","author":"Kademani","year":"2006","journal-title":"Mayo. Clin. Proc."},{"key":"10.1016\/j.bone.2008.09.012_bib64","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1634\/theoncologist.2007-0159","article-title":"Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study","volume":"13","author":"Ibrahim","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.bone.2008.09.012_bib65","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.amjoto.2006.08.004","article-title":"Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals","volume":"28","author":"Magopoulos","year":"2007","journal-title":"Amer. J. Otolaryngol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208007886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208007886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T16:24:15Z","timestamp":1738427055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328208007886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S8756328208007886"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2008.09.012","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}